Variantyx

Variantyx is a precision medicine company offering genetic testing services for rare genetic disorders, reproductive health, and precision oncology. Its proprietary whole-genome sequencing (WGS) and data analysis platform, Genomic Intelligence, identifies unique genetic mutations in a patient’s tumor and predicts treatment response, offering healthcare providers and pharmaceutical companies diagnostics, treatment recommendations, and clinical trial information.

Its WGS-based approach, which uses multiple genomic technologies, can sequence the entire DNA and this data can be sliced based on the required analysis. It detects multiple types of variants including small sequence changes, large structural variants, mitochondrial variants (common in tumors), and tandem repeat mutations (found in neurological diseases). The company claims this approach allows it to provide insights and analytics that are currently not available through other diagnostic tests at the shortest turnaround time.